Toggle navigation
HOME
ABOUT US
NEWS
PRODUCTS
Commercial
R&D
CONTACT
Search
Navigation
Position
HOME
>
PRODUCTS
Commercial
R&D
●
4-[2-(Dimethylamino)ethoxy]benzylamine [20059-73-8]
●
Axitinib Intermediate (2-[(1H-Indazol-6-yl)thio]-N-methylbenzamide) [944835-85-2]
●
Axitinib Intermediate (2-[(3-Iodo-1H-indazol-6-yl)thio]-N-methylbenzamide) [1639137-80-6]
●
Axitinib Intermediate (2-[(1-Acetyl-3-iodo-1H-indazol-6-yl)thio]-N-methyl-benzamide) [1639138-00-3]
●
Bemotrizinol (Tinosorb S) [187393-00-6]
●
Caprylhydroxamic Acid (CHA) [7377-03-9]
●
Diethylaminohydroxybenzoyl hexyl benzoate (Uvinul A Plus) [302776-68-7]
●
Axitinib Intermediate (2-({1-Acetyl-3-[(E)-2-(2-pyridinyl)vinyl]-1H-indazol-6-yl}sulfanyl)-N-methylbenzamide) [1639137-80-6]
●
Rosiglitazone Maleate [155141-29-0]
●
CBZ-L-Alanine [1142-20-7]
●
Tryptamine (2-(1H-Indol-3-yl)ethanamine) [61-54-1]
●
Cocamide MEA [68140-00-1]
●
Rosiglitazone HCl [302543-62-0]
●
Chrysin (5,7-Dihydroxyflavone) [480-40-0]
●
Rosiglitazone L-Tartarate [397263-86-4]
<<
1
2
3
4
5
6
7
>>
HOME
CALL
E-MAIL
TOP